Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
Pfizer
UM Funding ID
FD03992
Sponsor
Pfizer
Category
International
Description
This competitive grant program seeks to support research studies that focus on generating evidence on the use of elranatamab in multiple myeloma in the real world setting. Individual projects requesting up to $200,000 will be considered, although smaller requests (around $50,000) are also encouraged.
The estimated total available budget related to this RFP is $500,000 USD.
VPRI Contact
David Landry
Research Contracts OfficerDavid [dot] .Landry [at] @umanitoba [dot] .ca
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Application | 04-Jul-2025 4:30 pm CST | 24-Jul-2025 11:59 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.